Dual GIP/GLP-1 receptor agonist
A dual GIP/GLP-1 receptor agonist studied for metabolic health and weight management, prescribed through licensed telehealth clinics.
Tirzepatide acts on two separate gut hormone pathways involved in appetite and glucose regulation. Telehealth programs typically require an intake review, lab work, and ongoing clinician follow-up before and during treatment.
More reading in Weight loss
From intake questionnaire to prescription to follow-up: what happens at each stage of a typical GLP-1 telehealth program.
Read more
A neutral breakdown of how these two GLP-1 medications differ in mechanism, typical program structure, and what questions to ask a provider.
Read more
A side by side look at licensed GLP-1 telehealth clinics: pricing clarity, clinician access, and what to verify before you enroll.
Read more